Tag: Krishna Mohan Puvvada
Budget 2025: Biotech stakeholders welcome focus on R&D, digitalization
Will the budget propel India's biotech industry toward becoming a global powerhouse, or are there gaps that need to be addressed? Here’s how the sector is responding.
“Novozymes is aiming for 100% renewable production sites by 2025”
Krishna Mohan Puvvada, Vice President- Middle East, Africa & India, Novozymes-South Asia shares insights into the latest happenings within the company, emerging industry trends, new initiatives, future plans and much more
BioVoice eMagazine August 2023 | Issue 8 | Volume 4
The current issue discusses both approved and pending bills related to bioscience sector in the Parliament. It features the power-packed interviews with Krishna Mohan Puvvada, Vice President, Novozymes-South Asia; Dr Radha Rangarajan, Director, Central Drug Research Institute; Vikram Thaploo, CEO-Telehealth, Apollo Hospitals; and Vaibhav Tewari, Co-founder & CEO, Portea Medical.
Biotech is the key to unlock a sustainable future
From addressing climate change, transforming food systems, and enabling healthier lives, the biotechnology has many more possibilities, writes Krishna Mohan Puvvada, Regional President, India, Novozymes
BioVoice eMagazine February 2023 Issue 2 Volume 4
Click to Read: February 2023 Edition of BioVoice eMagazine
The Cover Story in the February 2023 issue focuses on the ambitious US$ 300 billion bioeconomy...
BioVoice eMagazine January 2023 Issue 1 Volume 4
Click to Read: January 2023 Edition of BioVoice eMagazine
BioVoice News, India's leading B2B news media for BioTech, HealthTech and AgriTech, is celebrating its 7th anniversary...
“2021 holds a lot of promise for Novozymes”
In an exclusive interview with BioVoice, Krishna Mohan Puvvada – Regional President and Head, Consumer Biosolutions – India, Novozymes shared interesting insights on the latest activities, learnings from covid, future outlook and much more.................